G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 124 filers reported holding G1 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,408 | +2430.3% | 46,811 | +4274.9% | 0.00% | – |
| Q2 2023 | $2,664 | -57.8% | 1,070 | -54.6% | 0.00% | – |
| Q1 2023 | $6,319 | -84.6% | 2,358 | -68.7% | 0.00% | – |
| Q4 2022 | $40,910 | -18.2% | 7,534 | +89.7% | 0.00% | – |
| Q3 2022 | $50,000 | +194.1% | 3,972 | +15.9% | 0.00% | – |
| Q2 2022 | $17,000 | -90.2% | 3,428 | -85.0% | 0.00% | – |
| Q1 2022 | $174,000 | +28.9% | 22,917 | +204.6% | 0.00% | – |
| Q4 2020 | $135,000 | +132.8% | 7,524 | +50.5% | 0.00% | – |
| Q3 2020 | $58,000 | +383.3% | 5,000 | +975.3% | 0.00% | – |
| Q4 2019 | $12,000 | – | 465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |